U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257523) titled 'Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer' on Nov. 17.
Brief Summary: "This prospective, single-arm phase II study aims to evaluate the efficacy and safety of carbon ion radiotherapy in frail patients with histologically confirmed, non-metastatic pancreatic cancer who are not eligible for surgery or systemic chemotherapy. Frail status is defined as a Clinical Frailty Scale (CFS) score >=4 or the presence of significant medical comorbidities limiting aggressive treatment.
Carbon ion radiotherapy, known for its superior dose distribution and high linear energy transfer, may offer improved tumor control with acce...